These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1687644)

  • 1. Boundaries between promotion and progression during carcinogenesis. Proceedings of a conference. Cleveland, Ohio, September 28-30, 1988.
    Basic Life Sci; 1991; 57():1-372. PubMed ID: 1687644
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic susceptibility to tumor progression in mouse skin carcinogenesis.
    Stern MC; Conti CJ
    Prog Clin Biol Res; 1996; 395():47-55. PubMed ID: 8895983
    [No Abstract]   [Full Text] [Related]  

  • 3. Study on initiation of human lung carcinogenesis.
    Li Z; Qi Z; Wei H; Luo X; Feng Y
    J Environ Pathol Toxicol Oncol; 1993; 12(2):81-8. PubMed ID: 8189362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of multistage hepatocarcinogenesis.
    Poole TM; Chiaverotti TA; Carabeo RA; Drinkwater NR
    Prog Clin Biol Res; 1996; 395():33-45. PubMed ID: 8895982
    [No Abstract]   [Full Text] [Related]  

  • 5. Pre-cancerous steps in carcinogenesis. Their physiological adaptive nature.
    Farber E
    Biochim Biophys Acta; 1984; 738(4):171-80. PubMed ID: 6394048
    [No Abstract]   [Full Text] [Related]  

  • 6. Amplification potential in preneoplastic and neoplastic Syrian hamster embryo fibroblasts transformed by various carcinogens.
    Jonczyk P; White A; Lum K; Barrett JC; Tlsty TD
    Cancer Res; 1993 Jul; 53(13):3098-102. PubMed ID: 8319217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic model of transformation and neoplastic progression in laryngeal epithelium.
    Marcos CÁ; Alonso-Guervós M; Prado NR; Gimeno TS; Iglesias FD; Hermsen M; Llorente JL
    Head Neck; 2011 Feb; 33(2):216-24. PubMed ID: 20629083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orphan nuclear receptor constitutive active/androstane receptor-mediated alterations in DNA methylation during phenobarbital promotion of liver tumorigenesis.
    Phillips JM; Yamamoto Y; Negishi M; Maronpot RR; Goodman JI
    Toxicol Sci; 2007 Mar; 96(1):72-82. PubMed ID: 17172636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stomach - Genetic and epigenetic alterations of preneoplastic and neoplastic lesions.
    David S; Meltzer SJ
    Cancer Biomark; 2010; 9(1-6):493-507. PubMed ID: 22112492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor suppressive functions of RUNX3 in gastric carcinogenesis].
    Ito K
    Seikagaku; 2012 Apr; 84(4):278-82. PubMed ID: 22712235
    [No Abstract]   [Full Text] [Related]  

  • 12. Receptor-mediated biological processes. Implications for evaluating carcinogenesis. Proceedings of the 6th International Conference on Carcinogenesis and Risk Assessment. Austin, Texas, December 8-11, 1992.
    Prog Clin Biol Res; 1994; 387():1-359. PubMed ID: 7972242
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of cell transformation systems for carcinogenicity testing and mechanistic studies of carcinogenesis.
    Barrett JC; Hesterberg TW; Thomassen DG
    Pharmacol Rev; 1984 Jun; 36(2 Suppl):53S-70S. PubMed ID: 6473503
    [No Abstract]   [Full Text] [Related]  

  • 14. Proposed Terminology and Classification of Pre-Malignant Neoplastic Conditions: A Consensus Proposal.
    Valent P; Akin C; Arock M; Bock C; George TI; Galli SJ; Gotlib J; Haferlach T; Hoermann G; Hermine O; Jäger U; Kenner L; Kreipe H; Majeti R; Metcalfe DD; Orfao A; Reiter A; Sperr WR; Staber PB; Sotlar K; Schiffer C; Superti-Furga G; Horny HP
    EBioMedicine; 2017 Dec; 26():17-24. PubMed ID: 29203377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis.
    Breivik J; Gaudernack G
    Semin Cancer Biol; 1999 Aug; 9(4):245-54. PubMed ID: 10448112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical molecular determinant of carcinogenesis. Proceedings of The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston's Thirty-ninth Symposium on Fundamental Cancer Research. 16-19 September 1986, Houston, Texas.
    Symp Fundam Cancer Res; 1986; 39():1-196. PubMed ID: 3423467
    [No Abstract]   [Full Text] [Related]  

  • 17. Barriers to Ras transformation.
    Ferbeyre G
    Nat Cell Biol; 2007 May; 9(5):483-5. PubMed ID: 17473855
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased mutagen-induced chromosome damage in patients with transformed laryngeal pre-cancerosis.
    Gallo O; Santoro R; Lenzi S; Boddi V; Giovannucci-Uzielli ML
    Int J Cancer; 1996 Dec; 68(6):700-3. PubMed ID: 8980169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transition to pancreatic cancer in response to carcinogen.
    Bockman DE
    Langenbecks Arch Surg; 2008 Jul; 393(4):557-60. PubMed ID: 18189145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell differentiation and tumor-promoting action in skin carcinogenesis.
    Raick AN
    Cancer Res; 1974 Nov; 34(11):2915-25. PubMed ID: 4472445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.